Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors

Dimitriou, F., Orloff, M. M., Koch Hein, E. C., Cheng, P. F., Hughes, I. F., Simeone, E., Montazeri, K., Grover, P., Mehmi, I., Gerard, C. L., Gaudy-Marqueste, C., Grob, J.-J., Michielin, O., Hamid, O., Long, G. V., Sullivan, R., Kapiteijn, E., Johnson, D. B., Ascierto, P. A., … Dummer, R. (2025). Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors. European Journal of Cancer, 214, 115161. https://doi.org/10.1016/j.ejca.2024.115161
Authors:
Florentia Dimitriou
Marlana Orloff
Erica C. Koch Hein
Phil F. Cheng
Isaac F Hughes
Ester Simeone
Kamaneh Montazeri
Piyush Grover
Inderjit Mehmi
Camille L. Gérard
C. Gaudy‐Marqueste
Jean-Jacques Grob
Olivier Michielin
Omid Hamid
Georgina V. Long
Ryan J. Sullivan
Ellen Kapiteijn
Douglas B. Johnson
Paolo A Ascierto
Anthony M. Joshua
Richard D. Carvajal
Marcus O. Butler
Jessica C. Hassel
Reinhard Dummer
Affiliated Authors:
Isaac F Hughes
Richard D. Carvajal
Author Keywords:
tebentafusp
immune checkpoint inhibitors
uveal melanoma
gna11
gnaq
Publication Type:
Article
Unique ID:
10.1016/j.ejca.2024.115161
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: